Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human PIP4K2B/PIP4KII-beta Protein, N-His

Catalog #:   YHF65401 Specific References (21) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P78356
Protein length: Ser2-Thr416
Overview

Catalog No.

YHF65401

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser2-Thr416

Predicted molecular weight

48.49 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P78356

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

1-phosphatidylinositol 5-phosphate 4-kinase 2-beta, Phosphatidylinositol 5-phosphate 4-kinase type-2 beta, PtdIns(5)P-4-kinase isoform 2-beta, Phosphatidylinositol 5-phosphate 4-kinase type II beta, PIP4KII-beta, Diphosphoinositide kinase 2-beta, PI(5)P 4-kinase type II beta, PIP5K2B, PIP4K2B

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human PIP4K2B/PIP4KII-beta protein
References

Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia., PMID:38851560

PIP4K2B Protein Regulation by NSD1 in HPV-Negative Head and Neck Squamous Cell Carcinoma., PMID:38539515

Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia., PMID:38069220

Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis., PMID:36982700

PIP4K2B is mechanoresponsive and controls heterochromatin-driven nuclear softening through UHRF1., PMID:36918565

PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells., PMID:36803256

Bacterial-Type Long-Chain Polyphosphates Bind Human Proteins in the Phosphatidylinositol Signaling Pathway., PMID:35909349

Identification of Metabolic-Associated Genes for the Prediction of Colon and Rectal Adenocarcinoma., PMID:33833525

High-throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype-specific serologically relevant biomarkers., PMID:33176066

Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain., PMID:32449185

PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia., PMID:31109595

PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism., PMID:31091439

The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature., PMID:29681787

The correlation analysis of miRNAs and target genes in metastasis of cervical squamous cell carcinoma., PMID:29343084

MANF regulates hypothalamic control of food intake and body weight., PMID:28924165

PIP4K2B: Coupling GTP Sensing to PtdIns5P Levels to Regulate Tumorigenesis., PMID:27132569

Gene expression profiling analysis of lung adenocarcinoma., PMID:26840709

The basal transcription complex component TAF3 transduces changes in nuclear phosphoinositides into transcriptional output., PMID:25866244

PIP4K and the role of nuclear phosphoinositides in tumour suppression., PMID:25728392

Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors., PMID:24209622

Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: A role for PIP4K2B in the regulation of E-cadherin expression., PMID:24127122

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human PIP4K2B/PIP4KII-beta Protein, N-His [YHF65401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only